Selected research
Industry Research
Pharma-Grade Hyaluronic Acid Industry Research Report 2026
Market perspective
The global Pharma-Grade Hyaluronic Acid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharma-Grade Hyaluronic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharma-Grade Hyaluronic Acid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharma-Grade Hyaluronic Acid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharma-Grade Hyaluronic Acid include Contipro, Fidia Farmaceutici, HTL Biotechnology, Kewpie, Seikagaku, AWA Biopharm and Bloomage Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharma-Grade Hyaluronic Acid market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharma-Grade Hyaluronic Acid Market by Company
Contipro
Fidia Farmaceutici
HTL Biotechnology
Kewpie
Seikagaku
AWA Biopharm
Bloomage Biotech
Pharma-Grade Hyaluronic Acid Segment by Type
Microbial Fermentation
Animal Tissue
Pharma-Grade Hyaluronic Acid Segment by Application
Injection Product
Eye Drops
Pharma-Grade Hyaluronic Acid Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma-Grade Hyaluronic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma-Grade Hyaluronic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma-Grade Hyaluronic Acid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharma-Grade Hyaluronic Acid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharma-Grade Hyaluronic Acid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharma-Grade Hyaluronic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microbial Fermentation
- Animal Tissue
Applications
- Injection Product
- Eye Drops
Companies covered
- Contipro
- Fidia Farmaceutici
- HTL Biotechnology
- Kewpie
- Seikagaku
- AWA Biopharm
- Bloomage Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pharma-Grade Hyaluronic Acid Market Size (2021-2032)
- 2.2.2 Global Pharma-Grade Hyaluronic Acid Sales (2021-2032)
- 2.2.3 Global Pharma-Grade Hyaluronic Acid Market Average Price (2021-2032)
- 2.3 Pharma-Grade Hyaluronic Acid by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Microbial Fermentation
- 2.3.3 Animal Tissue
- 2.4 Pharma-Grade Hyaluronic Acid by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Injection Product
- 2.4.3 Eye Drops
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharma-Grade Hyaluronic Acid Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pharma-Grade Hyaluronic Acid Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Pharma-Grade Hyaluronic Acid Revenue of Manufacturers (2021-2026)
- 3.4 Global Pharma-Grade Hyaluronic Acid Average Price by Manufacturers (2021-2026)
- 3.5 Global Pharma-Grade Hyaluronic Acid Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pharma-Grade Hyaluronic Acid, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pharma-Grade Hyaluronic Acid, Product Type & Application
- 3.8 Global Manufacturers of Pharma-Grade Hyaluronic Acid, Established Date
- 3.9 Global Pharma-Grade Hyaluronic Acid Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Contipro
- 4.1.1 Contipro Company Information
- 4.1.2 Contipro Business Overview
- 4.1.3 Contipro Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Contipro Pharma-Grade Hyaluronic Acid Product Portfolio
- 4.1.5 Contipro Recent Developments
- 4.2 Fidia Farmaceutici
- 4.2.1 Fidia Farmaceutici Company Information
- 4.2.2 Fidia Farmaceutici Business Overview
- 4.2.3 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fidia Farmaceutici Pharma-Grade Hyaluronic Acid Product Portfolio
- 4.2.5 Fidia Farmaceutici Recent Developments
- 4.3 HTL Biotechnology
- 4.3.1 HTL Biotechnology Company Information
- 4.3.2 HTL Biotechnology Business Overview
- 4.3.3 HTL Biotechnology Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 HTL Biotechnology Pharma-Grade Hyaluronic Acid Product Portfolio
- 4.3.5 HTL Biotechnology Recent Developments
- 4.4 Kewpie
- 4.4.1 Kewpie Company Information
- 4.4.2 Kewpie Business Overview
- 4.4.3 Kewpie Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kewpie Pharma-Grade Hyaluronic Acid Product Portfolio
- 4.4.5 Kewpie Recent Developments
- 4.5 Seikagaku
- 4.5.1 Seikagaku Company Information
- 4.5.2 Seikagaku Business Overview
- 4.5.3 Seikagaku Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Seikagaku Pharma-Grade Hyaluronic Acid Product Portfolio
- 4.5.5 Seikagaku Recent Developments
- 4.6 AWA Biopharm
- 4.6.1 AWA Biopharm Company Information
- 4.6.2 AWA Biopharm Business Overview
- 4.6.3 AWA Biopharm Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AWA Biopharm Pharma-Grade Hyaluronic Acid Product Portfolio
- 4.6.5 AWA Biopharm Recent Developments
- 4.7 Bloomage Biotech
- 4.7.1 Bloomage Biotech Company Information
- 4.7.2 Bloomage Biotech Business Overview
- 4.7.3 Bloomage Biotech Pharma-Grade Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bloomage Biotech Pharma-Grade Hyaluronic Acid Product Portfolio
- 4.7.5 Bloomage Biotech Recent Developments
5 Global Pharma-Grade Hyaluronic Acid Market Scenario by Region
- 5.1 Global Pharma-Grade Hyaluronic Acid Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharma-Grade Hyaluronic Acid Sales by Region: 2021-2032
- 5.2.1 Global Pharma-Grade Hyaluronic Acid Sales by Region: 2021-2026
- 5.2.2 Global Pharma-Grade Hyaluronic Acid Sales by Region: 2027-2032
- 5.3 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2021-2032
- 5.3.1 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2021-2026
- 5.3.2 Global Pharma-Grade Hyaluronic Acid Revenue by Region: 2027-2032
- 5.4 North America Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
- 5.4.1 North America Pharma-Grade Hyaluronic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pharma-Grade Hyaluronic Acid Sales by Country (2021-2032)
- 5.4.3 North America Pharma-Grade Hyaluronic Acid Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
- 5.5.1 Europe Pharma-Grade Hyaluronic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pharma-Grade Hyaluronic Acid Sales by Country (2021-2032)
- 5.5.3 Europe Pharma-Grade Hyaluronic Acid Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pharma-Grade Hyaluronic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pharma-Grade Hyaluronic Acid Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pharma-Grade Hyaluronic Acid Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
- 5.7.1 South America Pharma-Grade Hyaluronic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pharma-Grade Hyaluronic Acid Sales by Country (2021-2032)
- 5.7.3 South America Pharma-Grade Hyaluronic Acid Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pharma-Grade Hyaluronic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pharma-Grade Hyaluronic Acid Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pharma-Grade Hyaluronic Acid Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pharma-Grade Hyaluronic Acid Sales by Type (2021-2032)
- 6.1.1 Global Pharma-Grade Hyaluronic Acid Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Type (2021-2032)
- 6.2 Global Pharma-Grade Hyaluronic Acid Revenue by Type (2021-2032)
- 6.2.1 Global Pharma-Grade Hyaluronic Acid Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Type (2021-2032)
- 6.3 Global Pharma-Grade Hyaluronic Acid Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pharma-Grade Hyaluronic Acid Sales by Application (2021-2032)
- 7.1.1 Global Pharma-Grade Hyaluronic Acid Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Pharma-Grade Hyaluronic Acid Sales Market Share by Application (2021-2032)
- 7.2 Global Pharma-Grade Hyaluronic Acid Revenue by Application (2021-2032)
- 7.2.1 Global Pharma-Grade Hyaluronic Acid Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pharma-Grade Hyaluronic Acid Revenue Market Share by Application (2021-2032)
- 7.3 Global Pharma-Grade Hyaluronic Acid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pharma-Grade Hyaluronic Acid Value Chain Analysis
- 8.1.1 Pharma-Grade Hyaluronic Acid Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pharma-Grade Hyaluronic Acid Production Mode & Process
- 8.2 Pharma-Grade Hyaluronic Acid Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pharma-Grade Hyaluronic Acid Distributors
- 8.2.3 Pharma-Grade Hyaluronic Acid Customers
9 Global Pharma-Grade Hyaluronic Acid Analyzing Market Dynamics
- 9.1 Pharma-Grade Hyaluronic Acid Industry Trends
- 9.2 Pharma-Grade Hyaluronic Acid Industry Drivers
- 9.3 Pharma-Grade Hyaluronic Acid Industry Opportunities and Challenges
- 9.4 Pharma-Grade Hyaluronic Acid Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst